New contact lens microbiology workshop aims at preventing Acanthamoeba keratitis

NewsGuard 100/100 Score

The American Academy of Ophthalmology today announced a contact lens microbiology workshop on Sept. 12 aimed at preventing Acanthamoeba keratitis, a rare infection among contact lens wearers that causes severe eye pain, redness, light sensitivity and potential vision loss. The event is jointly sponsored by the Academy, the U.S. Food and Drug Administration (FDA), the Contact Lens Association of Ophthalmologists, the American Academy of Optometry and the American Optometric Association.

Acanthamoeba keratitis is caused by a parasite that can be found in water. Infections are often associated with poor hygiene and practices that expose contact lenses to water, such as swimming or showering while wearing contact lenses, and rinsing or storing lenses in water rather than disinfecting solution. While cases rarely occur, they can be difficult to diagnose and treat. Recent research found it takes an average of 27 days to diagnose Acanthamoeba, with 33 percent of the patients requiring a cornea transplant.[1] At the workshop, scientists, clinicians and industry experts will discuss methods for testing how effective contact lens care products are at disinfecting against Acanthamoeba, as well as other topics, such as emerging microbial threats.

The Centers for Disease Control and Prevention and the FDA issued a patient alert about Acanthamoeba keratitis in 2007 after 138 cases emerged following sales of a new multipurpose contact lens solution, which was then recalled by the manufacturer.[2] The infections created a growing concern over the organism and how to test for its presence in contact lens products. Today, there remains no required, standardized test method for disinfection efficacy against microbes like Acanthamoeba in contact lens products.

"While Acanthamoeba keratitis is rare, any cases are of concern as we currently do not have an FDA-approved, commercially available therapy for this type of infection," said Thomas Steinemann, M.D., the Academy's representative at the workshop and an ophthalmology professor at Case Western Reserve University in Cleveland, Ohio. "The course of treatment is long and unpleasant, and patients do have a chance of losing their vision."

The workshop, "Revamping Microbiological Test Methods for Contact Lenses, Products, and Accessories to Protect Health and Ensure Safety," will take place Sept.12, 2014, from 8 a.m. to 5:00 p.m. at the FDA White Oak Campus, 10903 New Hampshire Avenue in Silver Spring, Md.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Prime editing takes gene therapy to the next level